BridgeBio Pharma, Inc.

CIK 1743881 · View on SEC EDGAR ↗

Insider Activist

First SEC filing: June 19, 2018 · Latest: Aug. 18, 2025

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 6 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

6 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Jan. 26, 2021 BBIO P 14,428,836 — — 1,000 Direct — Acquired (price as of 2026-08-20)
July 3, 2019 BBIO P 882,353 $29.90 $26,382,355 24,575,501 Indirect +3.72% Acquired 178.4% (price as of 2026-08-20)
May 24, 2019 BBIO P 1,103,848 $25.93 $28,622,779 23,693,148 Direct +4.89% Acquired 221.1% (price as of 2026-08-20)
Dec. 10, 2018 BBIO P 2,664 $13.96 $37,189 22,589,300 Direct +0.01% Acquired 496.4% (price as of 2026-08-20)
Dec. 10, 2018 BBIO P 37,989 $13.29 $504,874 22,586,636 Direct +0.17% Acquired 526.4% (price as of 2026-08-20)
Dec. 10, 2018 BBIO S 2,664 $13.96 $37,189 22,589,300 Direct +0.01% Acquired 496.4% (price as of 2026-08-20)
Dec. 10, 2018 BBIO S 37,989 $13.29 $504,874 22,586,636 Direct +0.17% Acquired 526.4% (price as of 2026-08-20)
Dec. 7, 2018 BBIO P 4,860 $14.36 $69,790 22,548,647 Direct +0.02% Acquired 479.8% (price as of 2026-08-20)
Dec. 7, 2018 BBIO P 36,314 $13.94 $506,217 22,543,787 Direct +0.16% Acquired 497.2% (price as of 2026-08-20)
Dec. 7, 2018 BBIO S 4,860 $14.36 $69,790 22,548,647 Direct +0.02% Acquired 479.8% (price as of 2026-08-20)
Dec. 7, 2018 BBIO S 36,314 $13.94 $506,217 22,543,787 Direct +0.16% Acquired 497.2% (price as of 2026-08-20)
Dec. 6, 2018 BBIO P 38,970 $13.34 $519,860 22,507,473 Direct +0.17% Acquired 524.1% (price as of 2026-08-20)
Dec. 6, 2018 BBIO S 38,970 $13.34 $519,860 22,507,473 Direct +0.17% Acquired 524.1% (price as of 2026-08-20)
Dec. 5, 2018 BBIO P 1,103,848 $14.01 $15,464,910 22,468,503 Direct +5.17% Acquired 494.3% (price as of 2026-08-20)
Dec. 3, 2018 BBIO P 1,750,000 $15.50 $27,125,000 21,364,655 Direct +8.92% Acquired 437.1% (price as of 2026-08-20)
June 22, 2018 BBIO P 1,000,000 $17.00 $17,000,000 19,614,655 Direct +5.37% Acquired 389.7% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 22, 2018 BBIO Series Seed Preferred Stock Common Stock (15,347,219) — — 12,832,123 Disposed
June 22, 2018 BBIO Series B Preferred Stock Common Stock (3,479,198) — — 2,909,029 Disposed
June 22, 2018 BBIO Series B Preferred Stock Common Stock (397,385) — — 332,262 Acquired
June 22, 2018 BBIO Warrants Series B Preferred Stock (332,262) $10.83 — 332,262 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
June 19, 2018 BBIO Series Seed Preferred Stock→ Common Stock (15,347,219) 15,347,219 Direct
June 19, 2018 BBIO Series B Preferred Stock→ Common Stock (3,081,813) 3,081,813 Direct
June 19, 2018 BBIO Warrants→ Series B Preferred Stock (332,262) 332,262 Direct